GJA1 and Ventricular arrhythmia: In both patients and a mouse model with arrhythmogenic cardiomyopathy, levels of GJA1-20k are reduced in the heart, leading to a decrease in Cx43 expression at the ICDs and contributing to ventricular arrhythmias.